A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its CeQur Simplicity insulin delivery device. The company stated that ...

The prototype transdermal patches used in the animal studies were able to deliver insulin at therapeutic doses for up to five days, which could save up to 20 injections for someone with type 1 ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

The company stated that since its pilot market launch in April 2021, more than 6,000 diabetes patients are now using the device, which comprises a wearable insulin delivery patch for injection ...